TNFRSF9 and cranioectodermal dysplasia: Concerning CeD patients, an increase in Tumor Necrosis Factor Ligand Superfamily 13B (TNFSF13B) messenger RNA (mRNA) levels and a decrease in TNF Receptor Superfamily Member 9 (TNFRSF9) mRNA levels in whole blood has been observed [63].